Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes-Reference-Cited by-同舟云学术

Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes

Published:2003-12-11 Issue:1 Volume:124 Page:26-32
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Virchis Andres,Koh Mickey,Rankin Peter,Mehta Atul,Potter Michael,Victor Hoffbrand A.,Grant Prentice H.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04728.x/fullpdf

Reference33 articles.

1. Early allogeneic transplantation for refractory and relapsed acute leukaemia folowing remission induction with FLAG;Byrne;Leukemia,1999

2. Idarubicin in combination with intermediate- dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia;Carella;Leukemia,1993

3. High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia;Clavio;Haematologica,1996

4. Phase I study of liposomal daunorubicin in patients with acute leukemia;Cortes;Investigational New Drugs,1999

5. Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group;De Witte;Annals of Hematology,1996

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLAG/FLAG-Ida Regimen in Secondary and Relapsed/Refractory Acute Myeloid Leukemia—Even in the Era of New Treatment Modalities Still a Significant Player;Journal of Clinical Medicine;2024-03-22

2. Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada;Acta Haematologica;2024-02-21

3. A review of treatment options employed in relapsed/refractory AML;Hematology;2023-04-10

4. Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia;Leukemia & Lymphoma;2020-09-19

5. The role of cladribine in acute myeloid leukemia: an old drug up to new tricks;Leukemia & Lymphoma;2019-11-22